These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 36243008)
1. Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome. Malle L; Martin-Fernandez M; Buta S; Richardson A; Bush D; Bogunovic D Immunity; 2022 Nov; 55(11):2074-2084.e5. PubMed ID: 36243008 [TBL] [Abstract][Full Text] [Related]
2. Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome. Kong XF; Worley L; Rinchai D; Bondet V; Jithesh PV; Goulet M; Nonnotte E; Rebillat AS; Conte M; Mircher C; Gürtler N; Liu L; Migaud M; Elanbari M; Habib T; Ma CS; Bustamante J; Abel L; Ravel A; Lyonnet S; Munnich A; Duffy D; Chaussabel D; Casanova JL; Tangye SG; Boisson-Dupuis S; Puel A J Clin Immunol; 2020 Aug; 40(6):807-819. PubMed ID: 32572726 [TBL] [Abstract][Full Text] [Related]
3. Down syndrome and type I interferon: not so simple. Malle L; Bogunovic D Curr Opin Immunol; 2021 Oct; 72():196-205. PubMed ID: 34174697 [TBL] [Abstract][Full Text] [Related]
4. Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis. Tanaka MH; Giro EM; Cavalcante LB; Pires JR; Apponi LH; Valentini SR; Spolidório DM; Capela MV; Rossa C; Scarel-Caminaga RM Cytokine; 2012 Dec; 60(3):875-81. PubMed ID: 22995210 [TBL] [Abstract][Full Text] [Related]
5. Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks. Ling KH; Hewitt CA; Tan KL; Cheah PS; Vidyadaran S; Lai MI; Lee HC; Simpson K; Hyde L; Pritchard MA; Smyth GK; Thomas T; Scott HS BMC Genomics; 2014 Jul; 15(1):624. PubMed ID: 25052193 [TBL] [Abstract][Full Text] [Related]
6. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections. Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A Front Immunol; 2018; 9():2589. PubMed ID: 30473701 [TBL] [Abstract][Full Text] [Related]
7. The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action. Pfeffer LM; Basu L; Pfeffer SR; Yang CH; Murti A; Russell-Harde D; Croze E J Biol Chem; 1997 Apr; 272(17):11002-5. PubMed ID: 9110990 [TBL] [Abstract][Full Text] [Related]
8. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939 [TBL] [Abstract][Full Text] [Related]
9. HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells. Ickler J; Francois S; Widera M; Santiago ML; Dittmer U; Sutter K PLoS One; 2020; 15(1):e0218905. PubMed ID: 31935222 [TBL] [Abstract][Full Text] [Related]
10. SENP6 restricts the IFN-I-induced signaling pathway and antiviral activity by deSUMOylating USP8. Guo J; Zheng H; Xiong S Cell Mol Immunol; 2024 Aug; 21(8):892-904. PubMed ID: 38906982 [TBL] [Abstract][Full Text] [Related]
11. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1. Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772 [TBL] [Abstract][Full Text] [Related]
12. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein. Croze E; Russell-Harde D; Wagner TC; Pu H; Pfeffer LM; Perez HD J Biol Chem; 1996 Dec; 271(52):33165-8. PubMed ID: 8969169 [TBL] [Abstract][Full Text] [Related]
13. Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression. Lubick KJ; Robertson SJ; McNally KL; Freedman BA; Rasmussen AL; Taylor RT; Walts AD; Tsuruda S; Sakai M; Ishizuka M; Boer EF; Foster EC; Chiramel AI; Addison CB; Green R; Kastner DL; Katze MG; Holland SM; Forlino A; Freeman AF; Boehm M; Yoshii K; Best SM Cell Host Microbe; 2015 Jul; 18(1):61-74. PubMed ID: 26159719 [TBL] [Abstract][Full Text] [Related]
14. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon. Eantuzzi L; Eid P; Malorni W; Rainaldi G; Gauzzi MC; Pellegrini S; Belardelli F; Gessani S Eur J Immunol; 1997 May; 27(5):1075-81. PubMed ID: 9174595 [TBL] [Abstract][Full Text] [Related]
15. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Major J; Crotta S; Llorian M; McCabe TM; Gad HH; Priestnall SL; Hartmann R; Wack A Science; 2020 Aug; 369(6504):712-717. PubMed ID: 32527928 [TBL] [Abstract][Full Text] [Related]
16. The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities. Kalie E; Jaitin DA; Podoplelova Y; Piehler J; Schreiber G J Biol Chem; 2008 Nov; 283(47):32925-36. PubMed ID: 18801736 [TBL] [Abstract][Full Text] [Related]
17. Neuronal Ablation of Alpha/Beta Interferon (IFN-α/β) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-γ Responsiveness in Microglia/Macrophages. Hwang M; Bergmann CC J Virol; 2020 Sep; 94(20):. PubMed ID: 32796063 [TBL] [Abstract][Full Text] [Related]
18. Rotavirus Reprograms Multiple Interferon Receptors and Restricts Their Intestinal Antiviral and Inflammatory Functions. Sen A; Namsa ND; Feng N; Greenberg HB J Virol; 2020 Feb; 94(6):. PubMed ID: 31896593 [TBL] [Abstract][Full Text] [Related]
19. Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors. Powers RK; Culp-Hill R; Ludwig MP; Smith KP; Waugh KA; Minter R; Tuttle KD; Lewis HC; Rachubinski AL; Granrath RE; Carmona-Iragui M; Wilkerson RB; Kahn DE; Joshi M; Lleó A; Blesa R; Fortea J; D'Alessandro A; Costello JC; Sullivan KD; Espinosa JM Nat Commun; 2019 Oct; 10(1):4766. PubMed ID: 31628327 [TBL] [Abstract][Full Text] [Related]
20. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus. Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]